Proteasome mediated degradation of Id-1 is associated with TNFα-induced apoptosis in prostate cancer cells

Carcinogenesis

Volumn 27, Issue 2, 2006, Pages 205-215

  Ling, Ming Tat ^a   Kwok, Wai Kei ^a   Fung, Maggie K ^a   Xianghong, Wang ^a   Wong, Yong Chuan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE 3; HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 1; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEASOME; PROTEASOME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STABILITY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; DOWN-REGULATION; HALF-LIFE; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MALE; PROSTATIC NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN;

EID: 31544475135     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi217     Document Type: Article

References (33)

1. Benezra,R., Davis,R.L., Lockshon,D., Turner,D.L. and Weintraub,H. (1990) The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell, 61, 49-59.
2. Lister,J., Forrester,W.C. and Baron,M.H. (1995) Inhibition of an erythroid differentiation switch by the helix-loop-helix protein Id1. J. Biol. Chem., 270, 17939-17946.
3. Lyden,D., Young,A.Z., Zagzag,D. et al. (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature, 401, 670-677.
4. Ling,M.T., Wang,X, Ouyang,X.S., Lee,T.K.W., Fan,T.Y., Xu,K., Tsao,S.W. and Wong,Y.C. (2002) Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. Oncogene, 21, 1812-1822.
5. Wong,Y.C., Wang,X. and Ling,M.T. (2004) Id-1 expression and cell survival. Apoptosis, 9, 279-289.
6. Schoppmann,S.F., Schindl,M., Bayer,G., Aumayr,K., Dienes,J., Horvat,R., Rudas,M., Gnant,M., Jakesz,R. and Birner,P. (2003) Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer, 104, 677-682.
7. Schindl,M., Oberhuber,G., Obermair,A., Schoppmann,S.F., Karner,B. and Birner,P. (2001) Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res., 61, 5703-5706.
8. Ouyang,X.S., Wang,X., Lee,D.T., Tsao,S.W. and Wong,Y.C. (2002) Over expression of ID-1 in prostate cancer. J. Urol., 167, 2598-2602.
9. Ouyang,X.S., Wang,X, Ling,M.T., Wong,H.L., Tsao,S.W. and Wong,Y.C. (2002) Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis, 23, 721-725.
10. Lin,C.Q., Singh,J., Murata,K., Itahana,Y., Parrinello,S., Liang,S.H., Gillett,C.E., Campisi,J. and Desprez,P.Y. (2000) A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res., 60, 1332-1340.
11. Fong,S., Itahana,Y., Sumida,T. et al. (2003) Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl Acad. Sci. USA, 100, 13543-13548.
12. Ling,M.T., Wang,X., Lee,D.T., Tam,P.C., Tsao,S.W. and Wong,Y.C. (2004) Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Carcinogenesis, 25, 517-525.
13. Cheung,H.W., Ling,M.T., Tsao,S.W., Wong,Y.C. and Wang,X. (2004) Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis, 25, 881-887.
14. Ling,M.T., Wang,X., Ouyang,X.S., Xu,K., Tsao,S.W. and Wong,Y.C. (2003) Id-1 expression promotes cell survival through activation of NF-B signalling pathway in prostate cancer cells. Oncogene, 21, 4498-4508.
15. Lopez-Rovira,T., Chalaux,E., Massague,J., Rosa,J.L. and Ventura,F. (2002) Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem., 277, 3176-3185.
16. Korchynskyi,O. and ten Dijke,P. (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem., 277, 4883-4891.
17. Belletti,B., Drakas,R., Morrione,A., Tu,X., Prisco,M., Yuan,T., Casaburi,I. and Baserga,R. (2002) Regulation of Id1 protein expression in mouse embryo fibroblasts by the type 1 insulin-like growth factor receptor. Exp. Cell. Res., 277, 107-118.
18. Nagata,Y. and Todokoro,K. (1994) Activation of helix-loop-helix proteins Id1, Id2 and Id3 during neural differentiation. Biochem. Biophys. Res. Commun., 199, 1355-1362.
19. Ezura,Y., Tournay,O., Nifuji,A. and Noda,M. (1997) Identification of a novel suppressive vitamin D response sequence in the 5′-flanking region of the murine Id1 gene. J. Biol. Chem., 272, 29865-29872.
20. Ling,M.T., Wang,X., Tsao,S.W. and Wong,Y.C. (2002) Down-regulation of Id-1 expression is associated with TGF beta 1-induced growth arrest in prostate epithelial cells. Biochim. Biophys. Acta, 1570, 145-152.
21. Bounpheng,M.A., Dimas,J.J., Dodds,S.G. and Christy,B.A. (1999) Degradation of Id proteins by the ubiquitin-proteasome pathway. FASEB J., 13, 2257-2264.
22. Trausch-Azar,J.S., Lingbeck,J., Ciechanover,A. and Schwartz,A.L. (2004) Ubiquitin-Proteasome-mediated degradation of Id1 is modulated by MyoD. J. Biol. Chem., 279, 32614-32619.
23. Wei,N., Tsuge,T., Serino,G., Dohmae,N., Takio,K., Matsui,M. and Deng,X.W. (1998) The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr. Biol., 8, 919-922.
24. Berse,M., Bounpheng,M., Huang,X., Christy,B., Pollmann,C. and Dubiel,W. (2004) Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome. J. Mol. Biol., 343, 361-370.
25. Lingbeek,J.M., Trausch-Azar,J.S., Ciechanover,A. and Schwartz,A.L. (2003) Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD. J. Biol. Chem., 278, 1817-1823.
26. Zhao,X., van Steenbrugge,G.J. and Schroder,F.H. (1992) Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor. Urol. Res., 20, 193-197.
27. Igawa,T., Lin,F.F., Lee,M.S., Karan,D., Batra,S.K. and Lin,M.F. (2002) Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate, 50, 222-235.
28. Wajant,H., Pfizenmaier,K. and Scheurich,P. (2003) Tumor necrosis factor signaling. Cell Death Differ., 10, 45-65.
29. Hu,X., Bryington,M., Fisher,A.B., Liang,X., Zhang,X., Cui,D., Datta,I. and Zuckerman,K.S. (2002) Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest. J. Biol.,Chem., 277, 16528-16537.
30. Langen,R.C., Van Der Velden,J.L., Schols,A.M., Kelders,M.C., Wouters,E.F. and Janssen-Heininger,Y.M. (2004) Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J., 18, 227-237.
31. Reinstein,E., Scheffner,M., Oren,M., Ciechanover,A. and Schwartz,A. (2000) Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: Targeting via ubiquitination of the N-terminal residue. Oncogene, 19, 5944-5950.
32. Kang,Y., Chen,C.R. and Massague,J. (2003) A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell, 11, 915-926.
33. Tzeng,S.F., Kahn,M., Liva,S. and De Vellis,J. (1999) Tumor necrosis factor-alpha regulation of the Id gene family in astrocytes and microglia during CNS inflammatory injury. Glia, 26, 139-152.